Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242578 · ClinicalTrials.gov registry record · NA
Treating Refractory Schizophrenia With rTMS
A NA study, sponsored by Seton Healthcare Family.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02242578 is a NA study that was terminated before completion, run by Seton Healthcare Family. The registered enrollment target is 2 participants.
The verdict
NCT02242578, a NA study, was terminated before completion, sponsored by Seton Healthcare Family.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Symptomatic treatment of the negative symptoms in schizophrenia (such as social withdrawal, affective flattening, poor motivation, and apathy) with medications and psychotherapy are almost non-existent, whereas treatment of the positive symptoms (hallucinations and delusions) has been more effective with psychotropic medications. The proposed research on human subjects using a non-invasive technology (such as repetitive transcranial magnetic stimulation \[rTMS\]) will provide efficacy data for treating negative symptoms. The hypotheses are that 1) Cerebellar stimulation will cause activation of thalamic and frontal cortical networks associated with attentional processes as a component of the "distracted" affect of schizophrenia; 2) Cerebellar stimulation will cause activation of the reticular activating system (RAS), and this will allow the "mutism", which is a negative symptom, to be partially improved.
Interventions
- DEVICE 1 Hz rTMS
- DEVICE 10 Hz rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-01-24 |
| Est. Completion | 2018-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02242578
The ClinicalTrials.gov registry entry for NCT02242578 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seton Healthcare Family, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1 Hz rTMS is the first listed.
NCT02242578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02242578 about?
NCT02242578 is a clinical study titled "Treating Refractory Schizophrenia With rTMS". Symptomatic treatment of the negative symptoms in schizophrenia (such as social withdrawal, affective flattening, poor motivation, and apathy) with medications and psychotherapy are almost non-existent, whereas treatment of the positive symptoms (hallucinations and delusions) has been more effective...
What is the current status of trial NCT02242578?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2011-01-24. Estimated completion is 2018-06-11.
What interventions are being tested in trial NCT02242578?
The interventions under investigation include: 1 Hz rTMS (DEVICE), 10 Hz rTMS (DEVICE).
Who is sponsoring clinical trial NCT02242578?
This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.